Active-ingredient Dossier
Hydromorphone Hydrochloride
Active-ingredient Dossier for Hydromorphone Hydrochloride (opioid analgesic). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: DILAUDID
- Brand: DILAUDID-HP
- Brand: HYDROMORPHONE
- Brand: HYDROMORPHONE-HAMELN
- Brand: HYDROMORPHONE-HAMELN-HP
- Therapeutic area: Pain Management
What is
Hydromorphone Hydrochloride Hydromorphone hydrochloride is an opioid analgesic.
Australian brands containing
Hydromorphone Hydrochloride The following brands containing hydromorphone hydrochloride are registered on the ARTG: — DILAUDID — DILAUDID-HP — HYDROMORPHONE — HYDROMORPHONE-HAMELN — HYDROMORPHONE-HAMELN-HP
Therapeutic areas
Hydromorphone hydrochloride is registered in Pain & Anaesthesia, with 5 brands in this therapeutic area.
Sponsor landscape
Three sponsors market hydromorphone hydrochloride in Australia: Mundipharma, Hameln Pharma, and Juno Pharmaceuticals.
PBS and regulatory activity
Three brands containing hydromorphone hydrochloride have PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome on record is from 1 March 2018, and one brand has a PBAC outcome recorded.